XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.1

BASIS OF PRESENTATION (Tables)

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Revision of Previously Issued Financial Statements

Accordingly, the Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the three months ended March 31, 2024:

(In thousands, except per share data)			As previously reported						Impact of revision						As adjusted
Condensed Consolidated Statement of Operations
Revenue:
Financial Health			$	53,038					$	401					$	53,439
Patient Care			30,209						469						30,678
Total revenue			$	83,247					$	870					$	84,117
Operating loss			(1,458)						870						(588)
Loss before taxes			(4,108)						870						(3,238)
Benefit from income taxes			(1,592)						208						(1,384)
Net loss			(2,516)						662						(1,854)
Net loss per share - basic			$	(0.17)					$	0.04					(0.13)
Net loss per share - diluted			$	(0.17)					$	0.04					(0.13)
Condensed Consolidated Statement of Comprehensive Income (Loss)
Net income (loss)			$	(2,516)					$	662					$	(1,854)
Comprehensive income (loss)			(2,403)						662						(1,741)
Condensed Consolidated Statement of Equity
Retained Earnings Balance at December 31, 2023			$	8,132					$	(2,645)					$	5,487
Total Stockholders’ Equity at December 31, 2023			186,618						(2,645)						183,973
Net income (loss)			(2,516)						662						(1,854)
Retained Earnings			5,616						(1,983)						3,633
Total Stockholders’ Equity at March 31, 2024			184,673						(1,983)						182,690
Condensed Consolidated Statement of Cash Flows
Net income (loss)			$	(2,516)					$	662					$	(1,854)
Accounts receivable			(4,112)						(870)						(4,982)
Income taxes, net			477						208						685

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration